Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
“Although historically grouped together, viral-associated PCNSL subtypes are biologically distinct diseases. Each escapes immune control through a different mechanism, creating fundamentally different tumor microenvironments.” – Melinda Burgess, Researcher from the Department of Haematology at Princess Alexandra Hospital
Hematology January 20th 2026
Medical News Today (MNT)
The results underscore a clear message: timing and patient selection are key — and early diagnosis and intervention make the biggest difference.
Geriatrics November 3rd 2025
Cancer Therapy Advisor
Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin, followed by age and a family history of cancer.
Geriatrics October 8th 2025
Medical Xpress
Magnesium supplementation increases the gut microbes which have been shown to synthesize vitamin D in the gut without sunlight and locally inhibit colorectal cancer development.
Family Medicine/General Practice October 8th 2025
Castalin can boost the effectiveness of CHK1 inhibitors, a class of drugs currently in phase 1 clinical trials. When tested in cellular models of triple-negative breast cancer, one of the most aggressive forms of the disease, Castalin was shown to enhance the action of these inhibitors.
Clinical Pharmacology September 15th 2025
These results suggest that PARP inhibition represents a potential treatment strategy in HRR-deficient advanced biliary tract cancer, including the potential platform to investigate novel combination treatment strategies as well as consideration for a more selective biomarker selection.
Gastroenterology September 15th 2025